Halozyme Therapeutics shares owned by Camden Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Camden Asset Management
from 13F filings
Historical chart of Camden Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Camden Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Camden Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $41B | 41M | 1000.83 |
| 2024-06-30 | $71B | 75M | 953.31 |
| 2024-03-31 | $69B | 78M | 884.85 |
| 2023-12-31 | $72B | 83M | 864.40 |
| 2023-09-30 | $65B | 77M | 843.80 |
| 2023-06-30 | $64B | 78M | 830.57 |
| 2023-03-31 | $40B | 47M | 847.51 |
| 2022-12-31 | $56B | 58M | 968.13 |
| 2022-09-30 | $55M | 65M | 0.85 |
| 2022-06-30 | $63M | 71M | 0.88 |
| 2022-03-31 | $62M | 71M | 0.87 |